Fractalkine: A novel cardiac chemokine?

Cardiovascular Research

Volumn 92, Issue 3, 2011, Pages 361-362

  Elissa Altin, S ^a   Christian Schulze, P ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CD16 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; HYDROGEN PEROXIDE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; AORTA CONSTRICTION; BIOACCUMULATION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; EDITORIAL; HEART CELL CULTURE; HEART FAILURE; HEART INFARCTION; HEART INJURY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; IN VITRO STUDY; IN VIVO STUDY; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; CHEMOKINE CX3CL1; HEART FAILURE; MALE; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC;

EID: 81055133049     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr272     Document Type: Editorial

References (11)

1. Xuan W, Liao Y, Chen B, Huang Q, Xu D, Liu Y et al. Detrimental effect of fractalkine on myocardial ischaemia and heart failure. Cardiovasc Res 2011;92: 385-393.
2. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997;385:640-644.
3. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997;91:521-530. (Pubitemid 27508241)
4. Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem 2001;276:37993-38001.
5. Moatti D, Faure S, Fumeron F, Amara Mel-W, Seknadji P, McDermott DH et al. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 2001;97:1925-1928. (Pubitemid 32239068)
6. Chen S, Bacon KB, Li L, Garcia GE, Xia Y, Lo D et al. In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Exp Med 1998;188:193-198. (Pubitemid 28328617)
7. Soriano SG, Amaravadi LS,Wang YF, Zhou H, Yu GX, Tonra JR et al. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J Neuroimmunol 2002;125: 59-65. (Pubitemid 34327454)
8. Husberg C, Nygard S, Finsen AV, Damas JK, Frigessi A, Oie E et al. Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure. J Mol Cell Cardiol 2008;45:261-269.
9. Yoshimoto S, Nakatani K, Iwano M, Asai O, Samejima K, Sakan H et al. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis. Am J Kidney Dis 2007;50:47-58. (Pubitemid 46970800)
10. Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Frankenberger B et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 2002;168:3536-3542. (Pubitemid 34250422)
11. Frankenberger M, Sternsdorf T, Pechumer H, Pforte A, Ziegler-Heitbrock HW. Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood 1996;87:373-377. (Pubitemid 26011852)